title: A systematic assessment of the concept and practice of public-private mix for tuberculosis care and control.
abstract: BACKGROUND
  The STOP TB Partnership aims to improve global tuberculosis (TB) control through expanding access to the directly observed treatment short course (DOTS) strategy. One approach to this is 'Engaging all Care Providers', which evolved from 'Public-Private Mix (PPM) DOTS'. The overall aim of this study was to systematically assess whether and to what degree the STOP TB Partnership's four global objectives of engaging all care providers are met through existing PPM interventions. These four objectives are; 1) Increase TB case detection; 2) Improve TB treatment outcomes; 3) Enhance access and equity; 4) Reduce financial burden on patients. The specific objectives of this assessment were to 1) Understand what PPM means to the STOP TB Partnership's PPM Subgroup and to National Tuberculosis Programme managers; 2) Scope the nature of existing country-level PPM interventions and 3) Review PPM practice against the global PPM objectives.
  
  
  METHODS
  We undertook a systematic, multi-facetted assessment. The methods included interviews with National Tuberculosis Programme managers from high burden countries, clarification of key issues with the STOP TB Partnership PPM secretariat and a review of publicly accessible reports and published articles on PPM projects. Both the literature review and interviews with the National Tuberculosis Programme managers yielded data on project characteristics; PPM models at country level; National Tuberculosis Programme partners; and mechanisms for engagement. Matrices were developed from the literature review and the interviews to show the relationship between services and service providers for different PPM projects. Data from the literature were assessed against each of the four global PPM objectives.
  
  
  RESULTS
  Twelve National Tuberculosis Programme managers from high burden countries were interviewed about the scope of PPM partnerships. Understanding of PPM and types of engaged providers varied considerably; 'private-for-profit qualified clinical providers' were the dominant category. The literature review yielded information on 22 projects in which 'private-for-profit qualified clinical providers' were again the dominant category. The contributions made by 'private-for-profit qualified clinical providers' and 'Non Governmental Organisation qualified clinical providers', were assessed against the four global PPM objectives. Reporting on tuberculosis case detection and treatment outcomes was generally good and demonstrated important PPM contributions in these areas. Reporting on equity, access and reduced patient costs was often lacking or inconclusive.
  
  
  CONCLUSIONS
  PPM has improved case detection and treatment outcomes among patients seeking care with private providers. Evidence on reducing patient costs is inconclusive, and there is scope for increasing equity in access to care by systematically engaging those providers who are the primary agents for poor people seeking health care. Guidelines outlining which types of providers best contribute to achieving the four global objectives, along with the resources required by National Tuberculosis Programs for such engagement is needed.
authors.affiliation: International Department, The Norwegian Hearth and Lung Patient Organisation, LHL,(Storgata 33), Oslo, (0184), Norway. Rasmus.Malmborg@lhl.no.
authors.forename: Rasmus
authors.initials: R
authors.lastname: Malmborg
authors.forename: Gillian
authors.initials: G
authors.lastname: Mann
authors.forename: S Bertel
authors.initials: SB
authors.lastname: Squire
references.citation: Bull World Health Organ. 2006 Jun;84(6):437-45
references.pmid: 16799727
references.citation: Int J Tuberc Lung Dis. 2007 Jul;11(7):755-61
references.pmid: 17609050
references.citation: Lancet. 2006 Mar 18;367(9514):952-5
references.pmid: 16546550
references.citation: Int J Tuberc Lung Dis. 1998 Apr;2(4):324-9
references.pmid: 9559404
references.citation: Trans R Soc Trop Med Hyg. 2006 Apr;100(4):312-20
references.pmid: 16438997
references.citation: Int J Tuberc Lung Dis. 2004 May;8(5):552-9
references.pmid: 15137530
references.citation: Int J Tuberc Lung Dis. 2003 Dec;7(12):1147-53
references.pmid: 14677889
references.citation: Bull World Health Organ. 2006 Sep;84(9):752-8
references.pmid: 17128346
references.citation: Int J Tuberc Lung Dis. 2006 Sep;10(9):982-7
references.pmid: 16964788
references.citation: Glob Health Action. 2008 Dec 17;1:
references.pmid: 20027243
references.citation: Int J Tuberc Lung Dis. 2007 Oct;11(10):1101-7
references.pmid: 17945067
references.citation: Int J Tuberc Lung Dis. 2005 Aug;9(8):870-6
references.pmid: 16104633
references.citation: Int J Tuberc Lung Dis. 2003 Dec;7(12):1139-46
references.pmid: 14677888
references.citation: Int J Tuberc Lung Dis. 2007 Jan;11(1):110-2
references.pmid: 17217139
references.citation: Int J Tuberc Lung Dis. 2011 Jan;15(1):32-7
references.pmid: 21276293
references.citation: Int J Tuberc Lung Dis. 2006 Apr;10(4):460-2
references.pmid: 16602414
references.citation: Ann Afr Med. 2009 Jan-Mar;8(1):25-31
references.pmid: 19763003
references.citation: Indian J Tuberc. 2007 Apr;54(2):79-83
references.pmid: 17575679
references.citation: Int J Tuberc Lung Dis. 2009 Jan;13(1):112-8
references.pmid: 19105888
references.citation: Health Policy Plan. 2007 May;22(3):156-66
references.pmid: 17434870
references.citation: Bull World Health Organ. 2004 Aug;82(8):580-6
references.pmid: 15375447
references.citation: Bull World Health Organ. 2006 Nov;84(11):876-83
references.pmid: 17143461
references.citation: BMJ. 2010 Sep 13;341:c4739
references.pmid: 20837575
references.citation: Int J Tuberc Lung Dis. 2001 Apr;5(4):354-9
references.pmid: 11334254
references.citation: PLoS Med. 2011 Jan 25;8(1):e1000394
references.pmid: 21283606
references.citation: Int J Tuberc Lung Dis. 2006 Jan;10(1):58-62
references.pmid: 16466038
references.citation: Lancet. 2010 Jun 19;375(9732):2169-78
references.pmid: 20488514
references.citation: BMJ. 2006 Mar 11;332(7541):574-8
references.pmid: 16467347
references.citation: BMC Health Serv Res. 2010 May 07;10:113
references.pmid: 20459665
references.citation: Natl Med J India. 2003 Nov-Dec;16(6):321-7
references.pmid: 14765625
references.citation: Lancet. 2010 May 22;375(9728):1814-29
references.pmid: 20488524
references.citation: Indian J Chest Dis Allied Sci. 2004 Apr-Jun;46(2):133-6
references.pmid: 15072331
references.citation: Lancet. 2001 Sep 15;358(9285):912-6
references.pmid: 11567729
references.citation: Aust J Prim Health. 2010;16(4):284-90
references.pmid: 21138695
references.citation: Tuberculosis (Edinb). 2003;83(1-3):173-6
references.pmid: 12758208
references.citation: Int J Tuberc Lung Dis. 2009 Jun;13(6):705-12
references.pmid: 19460245
references.citation: Bull World Health Organ. 2006 Jun;84(6):479-84
references.pmid: 16799732
references.citation: Health Policy Plan. 2002 Mar;17(1):78-89
references.pmid: 11861589
references.citation: Int J Tuberc Lung Dis. 2006 Jul;10(7):795-801
references.pmid: 16848343
references.citation: Int J Tuberc Lung Dis. 2008 Nov;12(11):1274-8
references.pmid: 18926037
references.citation: J Pak Med Assoc. 2009 Feb;59(2):82-6
references.pmid: 19260569
references.citation: Trop Med Int Health. 2008 Mar;13(3):369-83
references.pmid: 18397400
references.citation: PLoS One. 2010 Aug 09;5(8):e12023
references.pmid: 20711502
references.citation: Int J Tuberc Lung Dis. 2005 Apr;9(4):403-8
references.pmid: 15830745
references.citation: Bull World Health Organ. 2004 Feb;82(2):92-8
references.pmid: 15042230
references.citation: Int J Tuberc Lung Dis. 2005 Sep;9(9):1013-7
references.pmid: 16158894
references.citation: Clin Vaccine Immunol. 2011 Oct;18(10):1616-27
references.pmid: 21832100
references.citation: Tuberculosis (Edinb). 2003;83(1-3):156-64
references.pmid: 12758206
references.citation: Int J Tuberc Lung Dis. 2008 Dec;12(12):1425-30
references.pmid: 19017452
references.citation: Int J Tuberc Lung Dis. 2007 Jan;11(1):33-9
references.pmid: 17217127
references.citation: Int J Tuberc Lung Dis. 2010 Jun;14(6):751-7
references.pmid: 20487615
references.citation: Bull World Health Organ. 2007 May;85(5):341-7
references.pmid: 17639217
references.citation: BMC Public Health. 2010 Sep 29;10:585
references.pmid: 20920267
references.citation: Lancet. 2010 Jun 19;375(9732):2179-91
references.pmid: 20488521
references.citation: PLoS One. 2010 Oct 27;5(10):e13593
references.pmid: 21048964
references.citation: Int J Tuberc Lung Dis. 2003 May;7(5):464-71
references.pmid: 12757048
references.citation: Lancet Infect Dis. 2010 Dec;10(12):886-92
references.pmid: 21050822
references.citation: Int J Tuberc Lung Dis. 2009 Jun;13(6):698-704
references.pmid: 19460244
references.citation: Indian J Chest Dis Allied Sci. 2004 Jan-Mar;46(1):27-37
references.pmid: 14870866
references.citation: PLoS One. 2011 Apr 04;6(4):e17601
references.pmid: 21483732
references.citation: BMC Public Health. 2011 May 26;11:393
references.pmid: 21615930
references.citation: Int J Tuberc Lung Dis. 2005 May;9(5):562-8
references.pmid: 15875930
references.citation: Int J Tuberc Lung Dis. 2003 Dec;7(12):1131-8
references.pmid: 14677887